Biofourmis Review

Biofourmis is a digital therapeutics and remote patient monitoring company that provides an end-to-end platform for collecting, analyzing, and acting on patient health data outside of traditional care settings. The platform integrates wearable devices with a cloud-based analytics engine to generate continuous streams of physiological data, which are then processed using machine learning models to surface clinically meaningful insights. The platform is designed for health systems, payers, pharmaceutical companies, and contract research organizations. For health systems, Biofourmis supports hospital-at-home and post-acute care programs that aim to reduce readmissions and extend care delivery beyond the hospital walls. For life sciences and pharma clients, it provides the infrastructure for decentralized and hybrid clinical trials, enabling remote patient enrollment, monitoring, and data collection. Key capabilities include FDA-cleared biosensor integration, real-time patient dashboards for clinical teams, automated alerting based on personalized patient baselines, and regulatory-grade data pipelines suitable for clinical trial use. The platform also includes care team workflow tools to help clinicians triage alerts and coordinate patient outreach. Biofourmis operates in the broader digital health and remote patient monitoring market, competing with platforms such as Current Health, Cadence, and Vivify Health. Its differentiation lies in its combination of continuous wearable data capture, AI-based predictive analytics, and support for both care delivery and research use cases under a single platform umbrella. The company is headquartered in Boston, Massachusetts, and has partnerships with major health systems and pharmaceutical organizations globally. Pricing and deployment are handled on an enterprise basis, and the platform is accessed primarily through web-based clinical dashboards and companion mobile applications for patients.